Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roche Corleen M. Insider Profile
4 Followers
Roche Corleen M., CFO at Immunome, holds ― shares in Immunome (Ticker: IMNM), holds 2.00K shares in CG Oncology, Inc. (Ticker: CGON). Most recently, Roche Corleen M. ― shares of Immunome on ― for an estimated value of ―.
Roche Corleen M. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Roche Corleen M.
Roche Corleen M.'s Trading History
Immunome
―
CFO
―
―
CG Oncology, Inc.
Jan 31, 2024
CFO
Informative Buy
38.00K
$65.60K
List of latest transactions for each holding click on a transaction to see Roche Corleen M.'s performance on stock
You May Also Like
Roche Corleen M. insider profile FAQ
What is the percentage of profitable transactions made by Roche Corleen M.?
The percentage of profitable transactions made by Roche Corleen M. is ―.
What is the average return per transaction made by Roche Corleen M.?
The average return per transaction made by Roche Corleen M. is ―.
What stocks does Roche Corleen M. hold?
Roche Corleen M. holds: IMNM, CGON stocks.
What was Roche Corleen M.’s latest transaction?
Roche Corleen M. latest transaction was an Uninformative Buy of ―.
What was Roche Corleen M.'s most profitable transaction?
Roche Corleen M.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Roche Corleen M.'s role in Immunome?
Roche Corleen M.'s role in Immunome is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.